Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQJU1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,366
Award facts
- Contract value 100% obligated
- $11,365.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,365.92 by the Defense Logistics Agency for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, represents a specific purchase against DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. The delivery order was issued without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The place of performance is Park Ridge, Illinois, where the vendor is headquartered.
This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a ceiling value of $499,999,999 and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare facilities worldwide. The contract authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables, positioning DMS Pharmaceutical Group as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQJU1?
SPE2DR26FQJU1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQJU1 worth?
The government has obligated $11,366 on SPE2DR26FQJU1.
Is contract SPE2DR26FQJU1 an order under another contract?
Yes. SPE2DR26FQJU1 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJU1 competed?
The extent of competition for SPE2DR26FQJU1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award